Nav1.7: a new channel for pain treatment
Following intriguing genetic discoveries in people with extreme sensitivity to pain, as well as some families who feel no pain at all, researchers and drug companies are optimistic that blocking a sodium channel called Nav1.7 may lead to a new generation of more sophisticated painkillers. Meanwhile, however, there is still debate about the underlying mechanism of Nav1.7 in pain.
In a world of chronic pain, individual treatment possible, Yale research shows
An investigation into the molecular causes of a debilitating condition known as “Man on Fire Syndrome” has led Yale researchers to develop a strategy that may lead to personalized pain therapy and predict which chronic pain patients will respond to treatment.
Yale team discovers unexpected source of diabetic neuropathy pain
Nearly half of all diabetics suffer from neuropathic pain, an intractable, agonizing and still mysterious companion of the disease. Now Yale researchers have identified an unexpected source of the pain and a potential target to alleviate it.
Yale Researchers Uncover Source of Mystery Pain
An estimated 20 million people in the United States suffer from peripheral neuropathy, marked by the degeneration of nerves and in some cases severe pain. There is no good treatment for the disorder and doctors can find no apparent cause in one of every three cases.
BBRF Honors Krystal with 2019 Colvin Prize for Outstanding Achievement in Mood Disorders Research
The Brain & Behavior Research Foundation (BBRF) has awarded its 2019 Colvin Prize for Outstanding Achievement in Mood Disorders Research to John H. Krystal, MD, Robert L. McNeil, Jr. Professor of Translational Research and Professor of Psychiatry and of Neuroscience at Yale School of Medicine.
New Faculty Friday: Yasmmyn Salinas, genetic epidemiologist, obesity specialist, social entrepreneur
Today we spotlight, Yasmmyn Salinas, assistant professor in the Department of Chronic Disease Epidemiology. Salinas has a Ph.D. (2019) and an M.P.H. (2014) in public health chronic disease epidemiology from YSPH. She has a B.S. in molecular cellular and developmental biology from Yale University (2010). Salinas did her postdoctoral training in Associate Professor Andrew DeWan’s lab at YSPH and she is a former McDougal Graduate Teaching Fellow.